Relation of nonalcoholic fatty liver disease to the metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis

Journal of Cardiovascular Computed Tomography

Volumn 7, Issue 5, 2013, Pages 311-318

  Zeb, Irfan ^a   Katz, Ronit ^b   Nasir, Khurram ^c,d,e,f,g   Ding, Jingzhong ^h   Rezaeian, Panteha ^g   Budoff, Matthew J ^g  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Baptist Health South Florida   (United States)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^e FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^h WAKE FOREST UNIVERSITY   (United States)

Author keywords

Fatty liver; MESA; Metabolic syndrome

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; ATTENUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FAT CONTENT; FEMALE; HUMAN; LIVER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; SELF REPORT; SPLEEN;

FATTY LIVER; MESA; METABOLIC SYNDROME;

ADIPOSITY; AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMANS; LIVER; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBESITY, ABDOMINAL; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPLEEN; UNITED STATES;

EID: 84888065527     PISSN: 19345925     EISSN: 1876861X     Source Type: Journal    
DOI: 10.1016/j.jcct.2013.08.011     Document Type: Article

References (39)

1. Kim H.J., Lee K.E., Kim D.J., et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004, 164:2169-2175.
2. Loria P., Lonardo A., Carulli N. Should nonalcoholic fatty liver disease be renamed?. Dig Dis 2005, 23:72-82.
3. Wanless I.R., Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990, 12:1106-1110.
4. Powell E.E., Cooksley W.G., Hanson R., Searle J., Halliday J.W., Powell L.W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990, 11:74-80.
5. Bacon B.R., Farahvash M.J., Janney C.G., Neuschwander-Tetri B.A. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994, 107:1103-1109.
6. Friis-Liby I., Aldenborg F., Jerlstad P., Rundstrom K., Bjornsson E. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol 2004, 39:864-869.
7. Chitturi S., Farrell G.C., George J. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?. JGastroenterol Hepatol 2004, 19:368-374.
8. Younossi Z.M., Stepanova M., Afendy M., et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011, 9:524-530 e521. quiz e560.
9. Cortez-Pinto H., Camilo M.E., Baptista A., De Oliveira A.G., De Moura M.C. Non-alcoholic fatty liver: another feature of the metabolic syndrome?. Clin Nutr 1999, 18:353-358.
10. Marchesini G., Brizi M., Bianchi G., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
11. Pagano G., Pacini G., Musso G., et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002, 35:367-372.
12. Schwimmer J.B., Deutsch R., Rauch J.B., Behling C., Newbury R., Lavine J.E. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. JPediatr 2003, 143:500-505.
13. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
14. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
15. Meigs J.B. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000, 152:908-911. discussion 912.
16. James P.T., Rigby N., Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004, 11:3-8.
17. Shirai K. Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Curr Med Res Opin 2004, 20:295-304.
18. Unger R.H. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003, 144:5159-5165.
19. Marchesini G., Bugianesi E., Forlani G., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37:917-923.
20. Marceau P., Biron S., Hould F.S., et al. Liver pathology and the metabolic syndrome X in severe obesity. JClin Endocrinol Metab 1999, 84:1513-1517.
21. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
22. Williams C.D., Stengel J., Asike M.I., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011, 140:124-131.
23. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002, 156:871-881.
24. Becker U., Deis A., Sorensen T.I., et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996, 23:1025-1029.
25. Coates R.A., Halliday M.L., Rankin J.G., Feinman S.V., Fisher M.M. Risk of fatty infiltration or cirrhosis of the liver in relation to ethanol consumption: a case-control study. Clin Invest Med 1986, 9:26-32.
26. Carr J.J., Nelson J.C., Wong N.D., et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005, 234:35-43.
27. Lee S.S., Park S.H., Kim H.J., et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. JHepatol 2010, 52:579-585.
28. Piekarski J., Goldberg H.I., Royal S.A., Axel L., Moss A.A. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980, 137:727-729.
29. Bydder G.M., Chapman R.W., Harry D., Bassan L., Sherlock S., Kreel L. Computed tomography attenuation values in fatty liver. JComput Tomogr 1981, 5:33-35.
30. Kawata R., Sakata K., Kunieda T., Saji S., Doi H., Nozawa Y. Quantitative evaluation of fatty liver by computed tomography in rabbits. AJR Am J Roentgenol 1984, 142:741-746.
31. Kodama Y., Ng C.S., Wu T.T., et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007, 188:1307-1312.
32. Park S.H., Kim P.N., Kim K.W., et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006, 239:105-112.
33. Zeb I., Li D., Nasir K., Katz R., Larijani V.N., Budoff M.J. Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol 2012, 19:811-818.
34. Maison P., Byrne C.D., Hales C.N., Day N.E., Wareham N.J. Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diabetes Care 2001, 24:1758-1763.
35. Ford E.S., Giles W.H., Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004, 27:2444-2449.
36. Omagari K., Kadokawa Y., Masuda J., et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. JGastroenterol Hepatol 2002, 17:1098-1105.
37. Hamaguchi M., Kojima T., Takeda N., et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007, 13:1579-1584.
38. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. NEngl J Med 2010, 363:1341-1350.
39. Longo R., Ricci C., Masutti F., et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993, 28:297-302.